Trademarkia Logo

Canada

C$
Trademark Search in Canada
OB CHRONICLE

View On IC.GC.CA

OB CHRONICLE
ADVERTISED

on 29 Nov 2024

Last Applicant/ Owned by

APHRIA INC.

265 Talbot Street WestLeamington

ONTARIO

CA

N8H4H3

Serial Number

2044921 filed on 11th Aug 2020

Registration Number

TMA1272189 registered on 29th Nov 2024

Registration expiry Date

29th Nov 2034

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

333 BAY STREET, SUITE 2400BAY ADELAIDE CENTRE, BOX 20TORONTO

ONTARIO

CA

M5H2T6

OB CHRONICLE

Trademark usage description

cannabis related products, namely oils, salves, concentrated pastes, tinctures, tablets and capsules, each containing cannabis for medicinal purposes Read More

Classification Information

Class [005]
Cannabis related products, namely oils, salves, concentrated pastes, tinctures, tablets and capsules, each containing cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils, salves, concentrated pastes, tinctures, tablets and capsules each containing resins and oils derived from cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of cannabis, namely resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; topical skin creams, bar and liquid soaps, bath additives, bath herbs, bath oils, body creams, body oils, face and body lotions, face and body milk, face lotion, and skin care preparations each containing derivatives of cannabis, for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; personal sexual lubricants; transdermal patches containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays containing cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis and marijuana for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis related product, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy

Classification kind code

11

Class [029]
Oils and resins derived from cannabis, for use as comestibles; cannabis related product, namely, oils for use as comestibles; oils derived from cannabis for use as comestibles; food products containing cannabis, cannabis resins and cannabis oils, namely butter

Classification kind code

11

Class [031]
Live cannabis plants; live marijuana plants; Cannabis seeds for agricultural purposes

Classification kind code

11

Class [034]
Dried marijuana, dried cannabis; derivatives of cannabis, namely resins and oils, for oral vaporizers for smoking; smokers' articles, namely, smoking pipes, pouches for use with marijuana and cannabis, lighters for smokers, oral vaporizers for smokers, grinders for use with cannabis and marijuana

Classification kind code

11

Mark Details

Serial Number

2044921

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 190
on 29th Nov 2024		Registration Pending
Submitted for opposition 55
on 29th Nov 2024		Registered
Submitted for opposition 42
on 11th Sept 2024		Advertised
Submitted for opposition 26
on 16th Aug 2024		Approved
Submitted for opposition 27
on 16th Aug 2024		Approval Notice Sent
Submitted for opposition 22
on 8th Aug 2024		Search Recorded
Submitted for opposition 287
on 17th Jun 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 11th Aug 2020		Filed
Submitted for opposition 1
on 11th Aug 2020		Created
Submitted for opposition 31
on 11th Aug 2020		Formalized